Lokhorst, Henk M

Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival. [electronic resource] - Haematologica Dec 2015 - e508-10 p. digital

Publication Type: Clinical Trial; Comparative Study; Letter; Research Support, Non-U.S. Gov't

1592-8721

10.3324/haematol.2015.128728 doi


Allografts
Autografts
Disease-Free Survival
Female
Humans
Male
Multiple Myeloma--mortality
Stem Cell Transplantation
Survival Rate